Medtronic PLC (NYSE:MDT) EVP Robert John White sold 52,166 shares of the firm’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $110.62, for a total transaction of $5,770,602.92. Following the completion of the sale, the executive vice president now owns 77,510 shares of the company’s stock, valued at approximately $8,574,156.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Robert John White also recently made the following trade(s):
- On Friday, November 1st, Robert John White sold 52,165 shares of Medtronic stock. The shares were sold at an average price of $109.33, for a total value of $5,703,199.45.
NYSE MDT traded up $0.08 during trading hours on Tuesday, reaching $110.99. The company’s stock had a trading volume of 3,576,205 shares, compared to its average volume of 5,077,267. The stock has a market cap of $148.91 billion, a PE ratio of 21.26, a PEG ratio of 2.70 and a beta of 0.60. Medtronic PLC has a fifty-two week low of $81.66 and a fifty-two week high of $114.46. The company’s 50-day moving average is $108.82 and its two-hundred day moving average is $103.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.28 and a current ratio of 2.77.
Several hedge funds have recently added to or reduced their stakes in the company. Prestige Wealth Management Group LLC increased its position in Medtronic by 14.8% during the third quarter. Prestige Wealth Management Group LLC now owns 3,133 shares of the medical technology company’s stock worth $340,000 after buying an additional 404 shares in the last quarter. Sandler Capital Management acquired a new position in Medtronic in the 3rd quarter valued at about $6,191,000. Voloridge Investment Management LLC raised its stake in Medtronic by 311.5% in the 3rd quarter. Voloridge Investment Management LLC now owns 155,930 shares of the medical technology company’s stock valued at $16,937,000 after purchasing an additional 118,039 shares during the last quarter. Bank of Hawaii lifted its holdings in Medtronic by 0.5% in the 3rd quarter. Bank of Hawaii now owns 25,143 shares of the medical technology company’s stock valued at $2,731,000 after purchasing an additional 126 shares in the last quarter. Finally, IHT Wealth Management LLC lifted its holdings in Medtronic by 53.2% in the 3rd quarter. IHT Wealth Management LLC now owns 7,917 shares of the medical technology company’s stock valued at $860,000 after purchasing an additional 2,749 shares in the last quarter. Institutional investors and hedge funds own 80.61% of the company’s stock.
A number of brokerages have recently issued reports on MDT. BMO Capital Markets increased their target price on Medtronic from $107.00 to $118.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 21st. Stifel Nicolaus lifted their price target on Medtronic from $95.00 to $112.00 and gave the company a “hold” rating in a research note on Wednesday, August 21st. Morgan Stanley upped their price objective on Medtronic from $105.00 to $111.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 21st. BTIG Research increased their price objective on Medtronic to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, August 21st. Finally, Needham & Company LLC reissued a “buy” rating and issued a $133.00 target price on shares of Medtronic in a report on Wednesday, August 28th. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Medtronic currently has a consensus rating of “Buy” and an average price target of $117.35.
Medtronic Company Profile
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group.
Further Reading: What is Considered a Good Return on Equity (ROE)?
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.